Monitor for Health Canada's Notice of Compliance as the next catalyst; absence of approval delays potential Canadian market entry and near-term revenue. The receipt of DINs suggests progress, but not final approval.
Price Chart
Executive Summary
Dr. Reddy's Laboratories confirmed it has not yet received Health Canada approval for its Semaglutide Injection, though it has obtained Drug Identification Numbers (DINs). The company remains engaged with regulators and plans to launch the product upon approval. No additional material information requiring disclosure was reported.
Key Facts
- Company has not yet received Health Canada approval (Notice of Compliance) for Semaglutide Injection.
- Drug Identification Numbers (DINs) for Semaglutide Injection were received on April 22, 2026.
- Filing is in response to a media report and confirms limited regulatory progress without new financial or clinical data.
- No material event or information beyond this update requires disclosure under SEBI rules.
Financial Impact
Undisclosed; regulatory delay may impact near-term revenue expectations for Semaglutide in Canada, but no financial figures provided.
Risk Factors
- Regulatory delay risk for Semaglutide Injection in Canada
- Market uncertainty due to lack of timeline for final approval
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000261 |
| Document: 0001575872-26-000261-index.html | 0001575872-26-000261 |
| Document: 0001575872-26-000261.txt | 0001575872-26-000261 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $11.91 $11.55 | ▼ −3.02% | ▼ −2.56% | $12.25 (+2.85%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Sep 10, 2026 22d ago | 6-K | $11.71 $11.90 | ▲ +1.62% | ▲ +0.77% | $12.25 (+4.61%) |
Aug 26, 2026 5w ago | 6-K | $12.22 $12.16 | ▼ −0.49% | ▼ −1.15% | $12.25 (+0.25%) |
Aug 17, 2026 6w ago | 6-K | $12.11 $12.15 | ▲ +0.33% | ▲ +1.01% | $12.25 (+1.16%) |
Aug 13, 2026 7w ago | 6-K | $12.42 $12.27 | ▼ −1.21% | ▼ −1.01% | $12.25 (−1.37%) |
Aug 10, 2026 7w ago | 6-K | $12.15 $12.45 | ▲ +2.47% | ▲ +2.79% | $12.25 (+0.82%) |
Aug 3, 2026 8w ago | 6-K | $12.07 $12.10 | ▲ +0.25% | ▼ −1.55% | $12.25 (+1.49%) |
Jul 29, 2026 9w ago | 6-K | $11.76 $11.83 | ▲ +0.60% | ▼ −1.08% | $12.25 (+4.17%) |
Jul 23, 2026 10w ago | 6-K | $11.80 $11.79 | ▼ −0.08% | ▼ −0.19% | $12.25 (+3.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access